Austria Cannabis Regulatory Snapshot 2018 - Manufacture Of CBD Is Permitted - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--May 1, 2019--The “Manufacture Of CBD Is Permitted: Austria Regulatory Snapshot” report has been added to ResearchAndMarkets.com’s offering.
In the latest regulatory snapshot, the report takes a look at Austria where cannabis is classified as a controlled drug.
However, in general the extraction and manufacture of CBD is allowed and hemp can be grown as long as the variety is on the Austrian list of plant varieties or in the European Common Catalogue of plant varieties. The author also finds that CBD products from industrial hemp with a THC level that does not exceed 0.3% are considered legal, and CBD food products may need an authorisation.
Key Topics Covered:
1. Executive summary
2. Planting and growing
3. Extraction and manufacture
4. Importing and exporting
5. Finished product
6. Edibles, oils and supplements
7. Topicals and creams
9. Relevant laws
For more information about this report visit https://www.researchandmarkets.com/r/vg23z0
View source version on businesswire.com:https://www.businesswire.com/news/home/20190501005447/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: PROFESSIONAL SERVICES CONSULTING
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 05/01/2019 05:29 AM/DISC: 05/01/2019 05:29 AM